These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

593 related items for PubMed ID: 29693120

  • 1. MicroRNA‑122 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K/AKT signaling in nasopharyngeal carcinoma in vitro.
    Yang Y, Li Q, Guo L.
    Mol Med Rep; 2018 Jun; 17(6):8244-8252. PubMed ID: 29693120
    [Abstract] [Full Text] [Related]

  • 2. Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway.
    Zhou XM, Sun R, Luo DH, Sun J, Zhang MY, Wang MH, Yang Y, Wang HY, Mai SJ.
    Oncotarget; 2016 Mar 22; 7(12):13634-50. PubMed ID: 26872369
    [Abstract] [Full Text] [Related]

  • 3. Identification of nasopharyngeal carcinoma metastasis-related biomarkers by iTRAQ combined with 2D-LC-MS/MS.
    Chen Z, Long L, Wang K, Cui F, Zhu L, Tao Y, Wu Q, Xiang M, Liang Y, Qiu S, Xiao Z, Yi B.
    Oncotarget; 2016 Jun 07; 7(23):34022-37. PubMed ID: 27145374
    [Abstract] [Full Text] [Related]

  • 4. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
    Wang B, Gu Q, Li J.
    Oncol Rep; 2017 Jul 07; 38(1):317-324. PubMed ID: 28586035
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway.
    Huang Q, Hou S, Zhu X, Liu S.
    World J Surg Oncol; 2020 Feb 03; 18(1):29. PubMed ID: 32013999
    [Abstract] [Full Text] [Related]

  • 6. TRIM29 promotes progression of thyroid carcinoma via activating P13K/AKT signaling pathway.
    Xu J, Li Z, Su Q, Zhao J, Ma J.
    Oncol Rep; 2017 Mar 03; 37(3):1555-1564. PubMed ID: 28098872
    [Abstract] [Full Text] [Related]

  • 7. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
    Hu W, Xiao L, Cao C, Hua S, Wu D.
    Oncotarget; 2016 Mar 22; 7(12):15161-72. PubMed ID: 26943030
    [Abstract] [Full Text] [Related]

  • 8. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
    Liu Y, Liu Q, Chen S, Liu Y, Huang Y, Chen P, Li X, Gao G, Xu K, Fan S, Zeng Z, Xiong W, Tan M, Li G, Zhang W.
    FASEB J; 2019 Nov 22; 33(11):11959-11972. PubMed ID: 31408612
    [Abstract] [Full Text] [Related]

  • 9. The important role of the receptor for activated C kinase 1 (RACK1) in nasopharyngeal carcinoma progression.
    Peng H, Gong PG, Li JB, Cai LM, Yang L, Liu YY, Yao KT, Li X.
    J Transl Med; 2016 May 11; 14(1):131. PubMed ID: 27170279
    [Abstract] [Full Text] [Related]

  • 10. ARHGAP42 promotes cell migration and invasion involving PI3K/Akt signaling pathway in nasopharyngeal carcinoma.
    Hu Q, Lin X, Ding L, Zeng Y, Pang D, Ouyang N, Xiang Y, Yao H.
    Cancer Med; 2018 Aug 11; 7(8):3862-3874. PubMed ID: 29936709
    [Abstract] [Full Text] [Related]

  • 11. c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC.
    Ke L, Xiang Y, Guo X, Lu J, Xia W, Yu Y, Peng Y, Wang L, Wang G, Ye Y, Yang J, Liang H, Kang T, Lv X.
    Oncotarget; 2016 May 10; 7(19):28340-55. PubMed ID: 27078847
    [Abstract] [Full Text] [Related]

  • 12. MiR-155 promotes proliferation and inhibits apoptosis of nasopharyngeal carcinoma cells through targeting PTEN-PI3K/AKT pathway.
    Zuo WN, Zhu H, Li LP, Jin AY, Wang HQ.
    Eur Rev Med Pharmacol Sci; 2019 Sep 10; 23(18):7935-7942. PubMed ID: 31599418
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Blocking PI3K/Akt signaling attenuates metastasis of nasopharyngeal carcinoma cells through induction of mesenchymal-epithelial reverting transition.
    Jiang H, Gao M, Shen Z, Luo B, Li R, Jiang X, Ding R, Ha Y, Wang Z, Jie W.
    Oncol Rep; 2014 Aug 10; 32(2):559-66. PubMed ID: 24889918
    [Abstract] [Full Text] [Related]

  • 15. MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma.
    Jiang N, Jiang X, Chen Z, Song X, Wu L, Zong D, Song D, Yin L, Wang D, Chen C, Bian X, He X.
    J Exp Clin Cancer Res; 2017 Oct 05; 36(1):138. PubMed ID: 28982387
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-142 promotes the development of nasopharyngeal carcinoma through targeting PTEN.
    Li DP, Chai W, Liu YH, Xu TT, Huang H.
    Eur Rev Med Pharmacol Sci; 2019 May 05; 23(9):3806-3812. PubMed ID: 31115007
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.